DK0555446T3 - Use of antagonists or partial agonists at the 5-HT1a receptor for the treatment and prevention of cognitive tests - Google Patents

Use of antagonists or partial agonists at the 5-HT1a receptor for the treatment and prevention of cognitive tests

Info

Publication number
DK0555446T3
DK0555446T3 DK92918251T DK92918251T DK0555446T3 DK 0555446 T3 DK0555446 T3 DK 0555446T3 DK 92918251 T DK92918251 T DK 92918251T DK 92918251 T DK92918251 T DK 92918251T DK 0555446 T3 DK0555446 T3 DK 0555446T3
Authority
DK
Denmark
Prior art keywords
antagonists
prevention
treatment
partial agonists
ht1a receptor
Prior art date
Application number
DK92918251T
Other languages
Danish (da)
Inventor
Jonathan Turner
Belinda Cole
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6443608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0555446(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0555446T3 publication Critical patent/DK0555446T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

The description relates to the novel use of antagonists or partial agonists on the 5HT1a? receptor to produce a medicament for the treatment and prevention of cognitive and pharmaceuticals containing these compounds.
DK92918251T 1991-08-31 1992-08-28 Use of antagonists or partial agonists at the 5-HT1a receptor for the treatment and prevention of cognitive tests DK0555446T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4135551A DE4135551A1 (en) 1991-08-31 1991-08-31 USE OF ANTAGONISTS OR PARTIAL AGONISTS ON THE 5-HT1A RECEPTOR TO TREAT AND PREVENT COGNITIVE DISORDERS
PCT/DE1992/000720 WO1993004681A1 (en) 1991-08-31 1992-08-28 Use of antagonists or partial agonists on the 5-ht1a receptor for the treatment and prevention of cognitive disorders

Publications (1)

Publication Number Publication Date
DK0555446T3 true DK0555446T3 (en) 2000-01-31

Family

ID=6443608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918251T DK0555446T3 (en) 1991-08-31 1992-08-28 Use of antagonists or partial agonists at the 5-HT1a receptor for the treatment and prevention of cognitive tests

Country Status (10)

Country Link
EP (1) EP0555446B1 (en)
JP (1) JPH06501713A (en)
AT (1) ATE182467T1 (en)
CA (1) CA2093009A1 (en)
DE (2) DE4135551A1 (en)
DK (1) DK0555446T3 (en)
ES (1) ES2135412T3 (en)
GR (1) GR3031514T3 (en)
HU (1) HUT63331A (en)
WO (1) WO1993004681A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223153D0 (en) * 1992-11-05 1992-12-16 Wyeth John & Brother Ltd Piperazine derivatives
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
EP0710481A1 (en) * 1994-11-02 1996-05-08 Duphar International Research B.V Use of flesinoxan for cognition enhancement
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
EP1075486A1 (en) 1998-05-06 2001-02-14 Duke University Method of treating bladder and lower urinary tract syndromes
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (en) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME
GT200600414A (en) 2005-09-12 2007-09-20 PIPERAZINE COMPOSITE GLUCURANATE SALT
TW200800306A (en) 2005-09-12 2008-01-01 Wyeth Corp Sustained-release formulation and uses thereof
GT200600416A (en) 2005-09-12 2007-09-20 SALTS SALCILATO AND GENTISATO OF A COMPOSITE OF PIPERAZINA
CN102918031A (en) 2010-05-28 2013-02-06 通用电气健康护理有限公司 Radiolabeled compounds and methods thereof
GB201112987D0 (en) 2011-07-28 2011-09-14 Ge Healthcare Ltd Novel compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (en) * 1976-06-23 1978-01-20 Roussel Uclaf APPLICATION AS A MEDICINAL PRODUCT OF A DERIVATIVE OF PIPERAZINE AND ITS SALTS
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4897399A (en) * 1988-04-20 1990-01-30 Ciba-Geigy Corp. Heterotertracyclic lactam derivatives, pharmaceutical compositions, and method of treating impaired memory and learning
GB2222768B (en) * 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
DE4039631A1 (en) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuro-protective combination for treating cerebral ischaemia - contains a 5-HT1A receptor agonist and 5-HT2 receptor antagonist

Also Published As

Publication number Publication date
HUT63331A (en) 1993-08-30
ATE182467T1 (en) 1999-08-15
GR3031514T3 (en) 2000-01-31
CA2093009A1 (en) 1993-03-01
JPH06501713A (en) 1994-02-24
EP0555446B1 (en) 1999-07-28
WO1993004681A1 (en) 1993-03-18
DE4135551A1 (en) 1993-03-04
ES2135412T3 (en) 1999-11-01
EP0555446A1 (en) 1993-08-18
HU9301250D0 (en) 1993-07-28
DE59209728D1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
DK0555446T3 (en) Use of antagonists or partial agonists at the 5-HT1a receptor for the treatment and prevention of cognitive tests
NO180538C (en) N-sulfonyl-2-oxoindole derivatives having affinity for vasopressin and / or ocytocin receptors, pharmaceutical compositions containing them and intermediates in the preparation of the derivatives
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
MX9102501A (en) METHANE SULFONAMIDE DERIVATIVES, FARDERIVED COMPOSITIONS OF METHANOSULFONAMIDE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCEDURE FOR SMACEUTICS THAT CONTAIN THEM AND PROCEDURE FOR U PREPARATION. ITS PREPARATION.
MX9205432A (en) INHIBITOR COMPOUNDS OF THE LEUCOTRENE BIOSYNTHESIS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
DE58909463D1 (en) New condensed heterocyclic compounds and their use in medicinal products.
MX9203187A (en) LIPOXIGENASE INHIBITING COMPOUNDS CONTAINING INDOL, BENZAFURAN AND BENZOTIOFEN.
DE3785684T2 (en) Pyrrolidinamide derivatives of acylamino acid, pharmaceutical composition and use.
CO4290432A1 (en) NEW DERIVATIVES OF PIRAZINACARBOXAMIDA, ITS PREPARATION AND ITS USE IN MEDICINES.
MX9102500A (en) BIPHENYLIUM COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
MX9202935A (en) DERIVATIVES OF 2,3-DIHYDRO-1H-INDENO AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
DE69510545D1 (en) CCK OR GASTRINE MODULATING 5-HETEROCYCLICYL-1,5-BENZODIAZEPINE
NO157135C (en) PROCEDURE FOR THERMAL DECOMPOSITION OF 1,2-DICHLORETHANE.
SE9003248D0 (en) DEVICE FOR TAKING OBJECTIVES, FOR EXAMPLE OF CONSIDERATION OF THE SAME
DK0512525T3 (en) Carbostyril derivatives and pharmaceuticals containing them for use as agents for amelioration of consciousness disorders, as a stimulant to the central nervous system or as a sigma receptor agonist
MX9202656A (en) COMPOUNDS OF TIADIAZABICICLOOCTANO OR TIADIAZABICICLOOCTENO, PROCEDURE FOR THEIR OBTAINING AND HERBICIDE COMPOSITION CONTAINING THEM.
DE69606777D1 (en) NAPHTHAMIDE DERIVATIVES OF 3-BETA-AMINO AZABICYCLOOCTAN OR NONAN AS AN ANTIPESYCHOTIC MEDICINAL PRODUCT
NO883986L (en) PROCEDURE FOR THE PREPARATION OF N- (SUBSTITUTED ALKYLIDE) -1,2,3,4-TETRAHYDRO-9 ACRIDINAMINES AND USE THEREOF AS MEDICINES.
DK359887A (en) THERMOUS MATERIALS CONTAINING ACRYLIC POLYMERS PRACTICALLY FREE OF AEACTIVE HYDROGEN GROUP
MX9202432A (en) 4,5-DIHYDRO-1,4-BENZOTIAZEPIN-3 (2H) ONAS COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NO910991L (en) PROCEDURE AND APPARATUS USED FOR THE CONVERSION OF PROBLEM WASTE TO UNSAFE AGENT.
DK204891D0 (en) UNKNOWN UNKNOWN CYANOALKYLBENZAMIDE DERIVATIVES, PROCEDURES FOR THE PRODUCTION THEREOF, AND USE OF SUCH CYANOALKYLBENZAMIDE DERIVATIVES AS INTERMEDIATE-SUBSTIDLYZE-METHYLENZED
DK363685A (en) CATALYST COMPOSITION AND ITS USE FOR THE PREPARATION OF HYDROGEN CONNECTIVE COMPOUNDS
NO885406L (en) PROCEDURE FOR THE PREPARATION OF 4-HETEROARYL-1,3-BENZODIAZEPINES AND 2-SUBSTITUTED-ALFA (HETERO-ARYL) BENZENETANAMINES AND USE THEREOF AS MEDICINES.
ES2008640A4 (en) AMINOPROPANOL DERIVATIVES OF COMPOUNDS OF 3- (3-HYDROXIPHENYL) -1-PROPANONE, PROCEDURE FOR ITS MANUFACTURE AND MEDICINES CONTAINING THESE COMPOUNDS.